Last night (Tuesday 19th May), members of the team here at Trinity PR helped to celebrate the UK launch of a pioneering organisation, devoted to advancing medical product and drug development.
The Critical Path Institute (C-Path) is an independent, non-profit organization established in 2005 in Tuscon, Arizona. They received continued support from the Arizona community, Science Foundation Arizona, and the U.S. Food and Drug Administration (FDA).
This helped them in their mission that is to catalyse the development of new approaches, which advance medical innovation and regulatory science, accelerating the path to a healthier world.
The celebrations followed on from a brand new International Neonatal Consortium, which C-Path formed. The launch took place at the European Medicines Agency (EMA) during a widely attended workshop focused on the needs of the neonate.
The night proved a successful opportunity for networking and to hear a few speeches from members and experts at C-Path and the newly launched consortium, detailing future aims and goals.
As an international leader in forming collaborations, C-Path has now established nine global, public-private partnerships that currently include over 1,000 scientists from government and regulatory agencies, academia, patient advocacy organizations, and dozens of major pharmaceutical companies.
C-Path is headquartered in Tucson, Arizona, but last night they celebrated the opening of their first UK office in London. Cementing C-Path’s growing reputation as a global facilitator of cross-disciplinary collaborations, the new office aims to better coordinate efforts among partners in Europe.
The team here at Trinity had a fantastic evening and very much hope to continue working with C-Path on their future goals here in the UK.
For more information about the organisation, check out their website www.c-path.org.